Who
William Jacob Savage
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Disc Medicine.
In numbers
- Trades disclosed
- 68
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $6.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Dec 2022
- Last trade
- 13 Apr 2026
- Last filed
- 15 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Apr 2026filed 15 Apr 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $233K3,531 at $66.12 | filing |
| 13 Apr 2026filed 15 Apr 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $147K2,200 at $66.81 | filing |
| 13 Apr 2026filed 15 Apr 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $233K3,531 at $66.12 | filing |
| 13 Apr 2026filed 15 Apr 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $147K2,200 at $66.81 | filing |
| 2 Mar 2026filed 4 Mar 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $288K4,392 at $65.52 | filing |
| 2 Mar 2026filed 4 Mar 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $198K2,986 at $66.41 | filing |
| 2 Mar 2026filed 4 Mar 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $288K4,392 at $65.52 | filing |
| 2 Mar 2026filed 4 Mar 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $198K2,986 at $66.41 | filing |
| 17 Feb 2026filed 17 Feb 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $205K3,256 at $62.86 | filing |
| 17 Feb 2026filed 17 Feb 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $205K3,256 at $62.86 | filing |
| 10 Feb 2026filed 11 Feb 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 10 Feb 2026filed 11 Feb 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,500 at $0.00 | filing |
| 10 Feb 2026filed 11 Feb 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,500 at $0.00 | filing |
| 10 Feb 2026filed 11 Feb 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 22 Dec 2025filed 29 Dec 2025 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,825 at $0.00 | filing |
| 22 Dec 2025filed 29 Dec 2025 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —219 at $0.00 | filing |
| 22 Dec 2025filed 29 Dec 2025 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —99 at $0.00 | filing |
| 22 Dec 2025filed 29 Dec 2025 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $28K2,825 at $9.86 | filing |
| 22 Dec 2025filed 29 Dec 2025 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $2,159219 at $9.86 | filing |
| 22 Dec 2025filed 29 Dec 2025 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $1,33799 at $13.50 | filing |
News
Disc Medicine (NASDAQ:IRON) Director Sells 10,994 Shares of StockIRON · themarketsdaily.com · 21 Oct 2026Disc Medicine Prices $450 Mln Offering Of Shares At $75/shr To Fund Pipeline DevelopmentIRON · finanzen.ch · 21 Oct 2026Disc Medicine Launches $350M Stock Offering Following Positive Phase 3 ResultsIRON · rttnews.com · 20 Oct 2026
0 headlines in the last 90 days name William Jacob Savage; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.